Kettering General Hospital (KGH) is one of nine NHS endoscopy units taking part in the first UK clinical trial of an innovative artificial intelligence (AI) device which could help better detect bowel cancer.
The ground-breaking study – called COLO-DETECT - is being led by leading Gastroenterologists at South Tyneside and Sunderland NHS Foundation Trust.
The units are trialling the use of GI Genius, an AI device designed to help clinicians identify polyps during colonoscopies – examinations using a flexible camera to detect changes or abnormalities in the bowel (colon and rectum).
So far, 390 patients from across the country (see editor’s notes) have taken part in the study including 114 at Kettering General Hospital – making us one of the lead contributors to the research.
Read KGH in world-leading AI research…